Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis

NCT04851964 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

416

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

BIOLOGICAL: Experimental: Tezepelumab
OTHER: Placebo
DRUG: Mometasone furoate or equivalent intranasal corticosteroid

Sponsor

AstraZeneca

Collaborators

[object Object]